USANA Health Sciences, Inc. (NYSE: USNA) Stock Competitors & Peer Comparison
See USNA's competitors and their performance on the NYSE and across the wider stock market.
Peer Comparison Table: Household & Personal Products Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for USNA and its NYSE peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| USNA | $13.27 | +0.11% | 243M | 13.29 | $0.99 | N/A |
| PG | $143.71 | -0.46% | 339.9B | 20.60 | $6.94 | +3.00% |
| UL | $63.85 | +1.05% | 136.6B | 20.86 | $3.04 | +3.51% |
| CL | $90.56 | -0.34% | 71.8B | 23.92 | $3.75 | +2.34% |
| KVUE | $19.04 | -0.47% | 36.3B | 16.03 | $1.18 | +4.39% |
| KMB | $109.02 | -0.78% | 36.1B | 14.59 | $7.45 | +4.67% |
| EL | $99.60 | +1.62% | 34.8B | 43.54 | $2.21 | +1.44% |
| CHD | $97.74 | -1.28% | 23.1B | 27.37 | $3.56 | +1.24% |
| CLX | $105.82 | -1.93% | 12.8B | 19.15 | $5.54 | +4.64% |
| ELF | $100.86 | +1.21% | 5.8B | 24.67 | $3.99 | N/A |
Stock Comparison
The Procter & Gamble Company (NYSE: PG)
USNA vs PG Comparison August 2026
USANA Health Sciences, Inc. (NYSE: USNA) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USNA stands at 243M. In comparison, PG has a market cap of 339.9B. Regarding current trading prices, USNA is priced at $13.27 on the NYSE, while PG trades at $143.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USNA currently has a P/E ratio of 13.29, whereas PG's P/E ratio is 20.60. In terms of profitability, USNA's ROE is -0.04%, compared to PG's ROE of +0.30%. Regarding short-term risk, USNA is more volatile compared to PG. This indicates higher risk in terms of short-term price fluctuations for USNA.Check PG's competition here
Unilever PLC (NYSE: UL)
USNA vs UL Comparison August 2026
USANA Health Sciences, Inc. (NYSE: USNA) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USNA stands at 243M. In comparison, UL has a market cap of 136.6B. Regarding current trading prices, USNA is priced at $13.27 on the NYSE, while UL trades at $63.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USNA currently has a P/E ratio of 13.29, whereas UL's P/E ratio is 20.86. In terms of profitability, USNA's ROE is -0.04%, compared to UL's ROE of +0.36%. Regarding short-term risk, USNA is more volatile compared to UL. This indicates higher risk in terms of short-term price fluctuations for USNA.Check UL's competition here
Colgate-Palmolive Company (NYSE: CL)
USNA vs CL Comparison August 2026
USANA Health Sciences, Inc. (NYSE: USNA) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USNA stands at 243M. In comparison, CL has a market cap of 71.8B. Regarding current trading prices, USNA is priced at $13.27 on the NYSE, while CL trades at $90.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USNA currently has a P/E ratio of 13.29, whereas CL's P/E ratio is 23.92. In terms of profitability, USNA's ROE is -0.04%, compared to CL's ROE of +6.31%. Regarding short-term risk, USNA is more volatile compared to CL. This indicates higher risk in terms of short-term price fluctuations for USNA.Check CL's competition here
Kenvue Inc. (NYSE: KVUE)
USNA vs KVUE Comparison August 2026
USANA Health Sciences, Inc. (NYSE: USNA) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USNA stands at 243M. In comparison, KVUE has a market cap of 36.3B. Regarding current trading prices, USNA is priced at $13.27 on the NYSE, while KVUE trades at $19.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USNA currently has a P/E ratio of 13.29, whereas KVUE's P/E ratio is 16.03. In terms of profitability, USNA's ROE is -0.04%, compared to KVUE's ROE of +0.16%. Regarding short-term risk, USNA is more volatile compared to KVUE. This indicates higher risk in terms of short-term price fluctuations for USNA.Check KVUE's competition here
Kimberly-Clark Corporation (NASDAQ: KMB)
USNA vs KMB Comparison August 2026
USANA Health Sciences, Inc. (NYSE: USNA) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USNA stands at 243M. In comparison, KMB has a market cap of 36.1B. Regarding current trading prices, USNA is priced at $13.27 on the NYSE, while KMB trades at $109.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USNA currently has a P/E ratio of 13.29, whereas KMB's P/E ratio is 14.59. In terms of profitability, USNA's ROE is -0.04%, compared to KMB's ROE of +1.23%. Regarding short-term risk, USNA is more volatile compared to KMB. This indicates higher risk in terms of short-term price fluctuations for USNA.Check KMB's competition here
The Estée Lauder Companies Inc. (NYSE: EL)
USNA vs EL Comparison August 2026
USANA Health Sciences, Inc. (NYSE: USNA) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USNA stands at 243M. In comparison, EL has a market cap of 34.8B. Regarding current trading prices, USNA is priced at $13.27 on the NYSE, while EL trades at $99.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USNA currently has a P/E ratio of 13.29, whereas EL's P/E ratio is 43.54. In terms of profitability, USNA's ROE is -0.04%, compared to EL's ROE of +0.05%. Regarding short-term risk, USNA is less volatile compared to EL. This indicates lower risk in terms of short-term price fluctuations for USNA.Check EL's competition here
Church & Dwight Co., Inc. (NYSE: CHD)
USNA vs CHD Comparison August 2026
USANA Health Sciences, Inc. (NYSE: USNA) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USNA stands at 243M. In comparison, CHD has a market cap of 23.1B. Regarding current trading prices, USNA is priced at $13.27 on the NYSE, while CHD trades at $97.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USNA currently has a P/E ratio of 13.29, whereas CHD's P/E ratio is 27.37. In terms of profitability, USNA's ROE is -0.04%, compared to CHD's ROE of +0.18%. Regarding short-term risk, USNA is more volatile compared to CHD. This indicates higher risk in terms of short-term price fluctuations for USNA.Check CHD's competition here
The Clorox Company (NYSE: CLX)
USNA vs CLX Comparison August 2026
USANA Health Sciences, Inc. (NYSE: USNA) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USNA stands at 243M. In comparison, CLX has a market cap of 12.8B. Regarding current trading prices, USNA is priced at $13.27 on the NYSE, while CLX trades at $105.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USNA currently has a P/E ratio of 13.29, whereas CLX's P/E ratio is 19.15. In terms of profitability, USNA's ROE is -0.04%, compared to CLX's ROE of -18.94%. Regarding short-term risk, USNA is more volatile compared to CLX. This indicates higher risk in terms of short-term price fluctuations for USNA.Check CLX's competition here
e.l.f. Beauty, Inc. (NYSE: ELF)
USNA vs ELF Comparison August 2026
USANA Health Sciences, Inc. (NYSE: USNA) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USNA stands at 243M. In comparison, ELF has a market cap of 5.8B. Regarding current trading prices, USNA is priced at $13.27 on the NYSE, while ELF trades at $100.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USNA currently has a P/E ratio of 13.29, whereas ELF's P/E ratio is 24.67. In terms of profitability, USNA's ROE is -0.04%, compared to ELF's ROE of +0.05%. Regarding short-term risk, USNA is less volatile compared to ELF. This indicates lower risk in terms of short-term price fluctuations for USNA.Check ELF's competition here
Reynolds Consumer Products Inc. (NASDAQ: REYN)
USNA vs REYN Comparison August 2026
USANA Health Sciences, Inc. (NYSE: USNA) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USNA stands at 243M. In comparison, REYN has a market cap of 5.4B. Regarding current trading prices, USNA is priced at $13.27 on the NYSE, while REYN trades at $25.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USNA currently has a P/E ratio of 13.29, whereas REYN's P/E ratio is 14.91. In terms of profitability, USNA's ROE is -0.04%, compared to REYN's ROE of +0.15%. Regarding short-term risk, USNA is more volatile compared to REYN. This indicates higher risk in terms of short-term price fluctuations for USNA.Check REYN's competition here
Natura &Co Holding S.A. (NYSE: NTCO)
USNA vs NTCO Comparison August 2026
USANA Health Sciences, Inc. (NYSE: USNA) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USNA stands at 243M. In comparison, NTCO has a market cap of 4.6B. Regarding current trading prices, USNA is priced at $13.27 on the NYSE, while NTCO trades at $6.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USNA currently has a P/E ratio of 13.29, whereas NTCO's P/E ratio is -11.37. In terms of profitability, USNA's ROE is -0.04%, compared to NTCO's ROE of -0.15%. Regarding short-term risk, USNA is less volatile compared to NTCO. This indicates lower risk in terms of short-term price fluctuations for USNA.Check NTCO's competition here
Inter Parfums, Inc. (NASDAQ: IPAR)
USNA vs IPAR Comparison August 2026
USANA Health Sciences, Inc. (NYSE: USNA) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USNA stands at 243M. In comparison, IPAR has a market cap of 3.7B. Regarding current trading prices, USNA is priced at $13.27 on the NYSE, while IPAR trades at $114.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USNA currently has a P/E ratio of 13.29, whereas IPAR's P/E ratio is 21.94. In terms of profitability, USNA's ROE is -0.04%, compared to IPAR's ROE of +0.19%. Regarding short-term risk, USNA is more volatile compared to IPAR. This indicates higher risk in terms of short-term price fluctuations for USNA.Check IPAR's competition here
Central Garden & Pet Company (NASDAQ: CENT)
USNA vs CENT Comparison August 2026
USANA Health Sciences, Inc. (NYSE: USNA) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USNA stands at 243M. In comparison, CENT has a market cap of 2.8B. Regarding current trading prices, USNA is priced at $13.27 on the NYSE, while CENT trades at $44.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USNA currently has a P/E ratio of 13.29, whereas CENT's P/E ratio is 14.91. In terms of profitability, USNA's ROE is -0.04%, compared to CENT's ROE of +0.10%. Regarding short-term risk, USNA is more volatile compared to CENT. This indicates higher risk in terms of short-term price fluctuations for USNA.Check CENT's competition here
Newell Brands Inc. (NASDAQ: NWL)
USNA vs NWL Comparison August 2026
USANA Health Sciences, Inc. (NYSE: USNA) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USNA stands at 243M. In comparison, NWL has a market cap of 2.5B. Regarding current trading prices, USNA is priced at $13.27 on the NYSE, while NWL trades at $5.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USNA currently has a P/E ratio of 13.29, whereas NWL's P/E ratio is 10.72. In terms of profitability, USNA's ROE is -0.04%, compared to NWL's ROE of -0.09%. Regarding short-term risk, USNA is less volatile compared to NWL. This indicates lower risk in terms of short-term price fluctuations for USNA.Check NWL's competition here
Coty Inc. (NYSE: COTY)
USNA vs COTY Comparison August 2026
USANA Health Sciences, Inc. (NYSE: USNA) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USNA stands at 243M. In comparison, COTY has a market cap of 2.4B. Regarding current trading prices, USNA is priced at $13.27 on the NYSE, while COTY trades at $2.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USNA currently has a P/E ratio of 13.29, whereas COTY's P/E ratio is 15.25. In terms of profitability, USNA's ROE is -0.04%, compared to COTY's ROE of -0.18%. Regarding short-term risk, USNA is less volatile compared to COTY. This indicates lower risk in terms of short-term price fluctuations for USNA.Check COTY's competition here
Spectrum Brands Holdings, Inc. (NYSE: SPB)
USNA vs SPB Comparison August 2026
USANA Health Sciences, Inc. (NYSE: USNA) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USNA stands at 243M. In comparison, SPB has a market cap of 2B. Regarding current trading prices, USNA is priced at $13.27 on the NYSE, while SPB trades at $85.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USNA currently has a P/E ratio of 13.29, whereas SPB's P/E ratio is 13.26. In terms of profitability, USNA's ROE is -0.04%, compared to SPB's ROE of +0.04%. Regarding short-term risk, USNA is more volatile compared to SPB. This indicates higher risk in terms of short-term price fluctuations for USNA.Check SPB's competition here
Edgewell Personal Care Company (NYSE: EPC)
USNA vs EPC Comparison August 2026
USANA Health Sciences, Inc. (NYSE: USNA) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USNA stands at 243M. In comparison, EPC has a market cap of 1.3B. Regarding current trading prices, USNA is priced at $13.27 on the NYSE, while EPC trades at $27.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USNA currently has a P/E ratio of 13.29, whereas EPC's P/E ratio is 14.97. In terms of profitability, USNA's ROE is -0.04%, compared to EPC's ROE of -0.06%. Regarding short-term risk, USNA is less volatile compared to EPC. This indicates lower risk in terms of short-term price fluctuations for USNA.Check EPC's competition here
Oddity Tech Ltd. (NASDAQ: ODD)
USNA vs ODD Comparison August 2026
USANA Health Sciences, Inc. (NYSE: USNA) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USNA stands at 243M. In comparison, ODD has a market cap of 713M. Regarding current trading prices, USNA is priced at $13.27 on the NYSE, while ODD trades at $12.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USNA currently has a P/E ratio of 13.29, whereas ODD's P/E ratio is 9.62. In terms of profitability, USNA's ROE is -0.04%, compared to ODD's ROE of +0.14%. Regarding short-term risk, USNA is less volatile compared to ODD. This indicates lower risk in terms of short-term price fluctuations for USNA.Check ODD's competition here
Helen of Troy Limited (NASDAQ: HELE)
USNA vs HELE Comparison August 2026
USANA Health Sciences, Inc. (NYSE: USNA) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USNA stands at 243M. In comparison, HELE has a market cap of 641.2M. Regarding current trading prices, USNA is priced at $13.27 on the NYSE, while HELE trades at $28.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USNA currently has a P/E ratio of 13.29, whereas HELE's P/E ratio is 8.34. In terms of profitability, USNA's ROE is -0.04%, compared to HELE's ROE of -0.48%. Regarding short-term risk, USNA is more volatile compared to HELE. This indicates higher risk in terms of short-term price fluctuations for USNA.Check HELE's competition here
The Honest Company, Inc. (NASDAQ: HNST)
USNA vs HNST Comparison August 2026
USANA Health Sciences, Inc. (NYSE: USNA) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USNA stands at 243M. In comparison, HNST has a market cap of 546M. Regarding current trading prices, USNA is priced at $13.27 on the NYSE, while HNST trades at $5.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USNA currently has a P/E ratio of 13.29, whereas HNST's P/E ratio is 77.76. In terms of profitability, USNA's ROE is -0.04%, compared to HNST's ROE of -0.07%. Regarding short-term risk, USNA is less volatile compared to HNST. This indicates lower risk in terms of short-term price fluctuations for USNA.Check HNST's competition here
Magnera Corp (NYSE: MAGN)
USNA vs MAGN Comparison August 2026
USANA Health Sciences, Inc. (NYSE: USNA) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USNA stands at 243M. In comparison, MAGN has a market cap of 427.8M. Regarding current trading prices, USNA is priced at $13.27 on the NYSE, while MAGN trades at $12.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USNA currently has a P/E ratio of 13.29, whereas MAGN's P/E ratio is -5.81. In terms of profitability, USNA's ROE is -0.04%, compared to MAGN's ROE of -0.11%. Regarding short-term risk, USNA is less volatile compared to MAGN. This indicates lower risk in terms of short-term price fluctuations for USNA.Check MAGN's competition here
European Wax Center, Inc. (NASDAQ: EWCZ)
USNA vs EWCZ Comparison August 2026
USANA Health Sciences, Inc. (NYSE: USNA) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USNA stands at 243M. In comparison, EWCZ has a market cap of 319.1M. Regarding current trading prices, USNA is priced at $13.27 on the NYSE, while EWCZ trades at $5.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USNA currently has a P/E ratio of 13.29, whereas EWCZ's P/E ratio is 29.10. In terms of profitability, USNA's ROE is -0.04%, compared to EWCZ's ROE of +0.10%. Regarding short-term risk, USNA is more volatile compared to EWCZ. This indicates higher risk in terms of short-term price fluctuations for USNA.Check EWCZ's competition here
Yatsen Holding Limited (NYSE: YSG)
USNA vs YSG Comparison August 2026
USANA Health Sciences, Inc. (NYSE: USNA) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USNA stands at 243M. In comparison, YSG has a market cap of 281.8M. Regarding current trading prices, USNA is priced at $13.27 on the NYSE, while YSG trades at $2.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USNA currently has a P/E ratio of 13.29, whereas YSG's P/E ratio is -23.52. In terms of profitability, USNA's ROE is -0.04%, compared to YSG's ROE of -0.05%. Regarding short-term risk, USNA is more volatile compared to YSG. This indicates higher risk in terms of short-term price fluctuations for USNA.Check YSG's competition here
Acme United Corporation (AMEX: ACU)
USNA vs ACU Comparison August 2026
USANA Health Sciences, Inc. (NYSE: USNA) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USNA stands at 243M. In comparison, ACU has a market cap of 236.5M. Regarding current trading prices, USNA is priced at $13.27 on the NYSE, while ACU trades at $62.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USNA currently has a P/E ratio of 13.29, whereas ACU's P/E ratio is 26.75. In terms of profitability, USNA's ROE is -0.04%, compared to ACU's ROE of +0.08%. Regarding short-term risk, USNA is more volatile compared to ACU. This indicates higher risk in terms of short-term price fluctuations for USNA.Check ACU's competition here
Nu Skin Enterprises, Inc. (NYSE: NUS)
USNA vs NUS Comparison August 2026
USANA Health Sciences, Inc. (NYSE: USNA) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USNA stands at 243M. In comparison, NUS has a market cap of 225.8M. Regarding current trading prices, USNA is priced at $13.27 on the NYSE, while NUS trades at $4.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USNA currently has a P/E ratio of 13.29, whereas NUS's P/E ratio is 3.88. In terms of profitability, USNA's ROE is -0.04%, compared to NUS's ROE of -0.29%. Regarding short-term risk, USNA is more volatile compared to NUS. This indicates higher risk in terms of short-term price fluctuations for USNA.Check NUS's competition here
Pitanium Limited (NASDAQ: PTNM)
USNA vs PTNM Comparison August 2026
USANA Health Sciences, Inc. (NYSE: USNA) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USNA stands at 243M. In comparison, PTNM has a market cap of 207.9M. Regarding current trading prices, USNA is priced at $13.27 on the NYSE, while PTNM trades at $10.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USNA currently has a P/E ratio of 13.29, whereas PTNM's P/E ratio is 346.33. In terms of profitability, USNA's ROE is -0.04%, compared to PTNM's ROE of -0.99%. Regarding short-term risk, USNA is more volatile compared to PTNM. This indicates higher risk in terms of short-term price fluctuations for USNA.Check PTNM's competition here
Waldencast plc (NASDAQ: WALD)
USNA vs WALD Comparison August 2026
USANA Health Sciences, Inc. (NYSE: USNA) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USNA stands at 243M. In comparison, WALD has a market cap of 159.6M. Regarding current trading prices, USNA is priced at $13.27 on the NYSE, while WALD trades at $1.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USNA currently has a P/E ratio of 13.29, whereas WALD's P/E ratio is -2.25. In terms of profitability, USNA's ROE is -0.04%, compared to WALD's ROE of -0.48%. Regarding short-term risk, USNA is less volatile compared to WALD. This indicates lower risk in terms of short-term price fluctuations for USNA.Check WALD's competition here
Waldencast plc (NASDAQ: WALDW)
USNA vs WALDW Comparison August 2026
USANA Health Sciences, Inc. (NYSE: USNA) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USNA stands at 243M. In comparison, WALDW has a market cap of 136.1M. Regarding current trading prices, USNA is priced at $13.27 on the NYSE, while WALDW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USNA currently has a P/E ratio of 13.29, whereas WALDW's P/E ratio is -0.05. In terms of profitability, USNA's ROE is -0.04%, compared to WALDW's ROE of -0.48%. Regarding short-term risk, USNA is more volatile compared to WALDW. This indicates higher risk in terms of short-term price fluctuations for USNA.Check WALDW's competition here
Solesence, Inc. Common Stock (NASDAQ: SLSN)
USNA vs SLSN Comparison August 2026
USANA Health Sciences, Inc. (NYSE: USNA) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USNA stands at 243M. In comparison, SLSN has a market cap of 70M. Regarding current trading prices, USNA is priced at $13.27 on the NYSE, while SLSN trades at $0.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USNA currently has a P/E ratio of 13.29, whereas SLSN's P/E ratio is 80.54. In terms of profitability, USNA's ROE is -0.04%, compared to SLSN's ROE of -0.12%. Regarding short-term risk, USNA is less volatile compared to SLSN. This indicates lower risk in terms of short-term price fluctuations for USNA.Check SLSN's competition here
Upexi, Inc. (NASDAQ: UPXI)
USNA vs UPXI Comparison August 2026
USANA Health Sciences, Inc. (NYSE: USNA) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USNA stands at 243M. In comparison, UPXI has a market cap of 68.6M. Regarding current trading prices, USNA is priced at $13.27 on the NYSE, while UPXI trades at $1.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USNA currently has a P/E ratio of 13.29, whereas UPXI's P/E ratio is -0.21. In terms of profitability, USNA's ROE is -0.04%, compared to UPXI's ROE of -3.07%. Regarding short-term risk, USNA is less volatile compared to UPXI. This indicates lower risk in terms of short-term price fluctuations for USNA.Check UPXI's competition here
Grove Collaborative Holdings, Inc. (NYSE: GROV)
USNA vs GROV Comparison August 2026
USANA Health Sciences, Inc. (NYSE: USNA) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USNA stands at 243M. In comparison, GROV has a market cap of 44.1M. Regarding current trading prices, USNA is priced at $13.27 on the NYSE, while GROV trades at $1.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USNA currently has a P/E ratio of 13.29, whereas GROV's P/E ratio is -4.04. In terms of profitability, USNA's ROE is -0.04%, compared to GROV's ROE of -0.83%. Regarding short-term risk, USNA is more volatile compared to GROV. This indicates higher risk in terms of short-term price fluctuations for USNA.Check GROV's competition here
Axil Brands, Inc. (AMEX: AXIL)
USNA vs AXIL Comparison August 2026
USANA Health Sciences, Inc. (NYSE: USNA) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USNA stands at 243M. In comparison, AXIL has a market cap of 40.5M. Regarding current trading prices, USNA is priced at $13.27 on the NYSE, while AXIL trades at $6.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USNA currently has a P/E ratio of 13.29, whereas AXIL's P/E ratio is 49.54. In terms of profitability, USNA's ROE is -0.04%, compared to AXIL's ROE of +0.24%. Regarding short-term risk, USNA is less volatile compared to AXIL. This indicates lower risk in terms of short-term price fluctuations for USNA.Check AXIL's competition here
United-Guardian, Inc. (NASDAQ: UG)
USNA vs UG Comparison August 2026
USANA Health Sciences, Inc. (NYSE: USNA) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USNA stands at 243M. In comparison, UG has a market cap of 32.7M. Regarding current trading prices, USNA is priced at $13.27 on the NYSE, while UG trades at $7.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USNA currently has a P/E ratio of 13.29, whereas UG's P/E ratio is 13.69. In terms of profitability, USNA's ROE is -0.04%, compared to UG's ROE of +0.22%. Regarding short-term risk, USNA is less volatile compared to UG. This indicates lower risk in terms of short-term price fluctuations for USNA.Check UG's competition here
Big Tree Cloud Holdings Limited (NASDAQ: DSY)
USNA vs DSY Comparison August 2026
USANA Health Sciences, Inc. (NYSE: USNA) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USNA stands at 243M. In comparison, DSY has a market cap of 19.3M. Regarding current trading prices, USNA is priced at $13.27 on the NYSE, while DSY trades at $4.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USNA currently has a P/E ratio of 13.29, whereas DSY's P/E ratio is -0.45. In terms of profitability, USNA's ROE is -0.04%, compared to DSY's ROE of +14.77%. Regarding short-term risk, USNA is less volatile compared to DSY. This indicates lower risk in terms of short-term price fluctuations for USNA.Check DSY's competition here
Mannatech, Incorporated (NASDAQ: MTEX)
USNA vs MTEX Comparison August 2026
USANA Health Sciences, Inc. (NYSE: USNA) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USNA stands at 243M. In comparison, MTEX has a market cap of 12.3M. Regarding current trading prices, USNA is priced at $13.27 on the NYSE, while MTEX trades at $6.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USNA currently has a P/E ratio of 13.29, whereas MTEX's P/E ratio is -0.95. In terms of profitability, USNA's ROE is -0.04%, compared to MTEX's ROE of +3.37%. Regarding short-term risk, USNA is less volatile compared to MTEX. This indicates lower risk in terms of short-term price fluctuations for USNA.Check MTEX's competition here
Park Ha Biological Technology Co., Ltd. (NASDAQ: PHH)
USNA vs PHH Comparison August 2026
USANA Health Sciences, Inc. (NYSE: USNA) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USNA stands at 243M. In comparison, PHH has a market cap of 10M. Regarding current trading prices, USNA is priced at $13.27 on the NYSE, while PHH trades at $0.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USNA currently has a P/E ratio of 13.29, whereas PHH's P/E ratio is -0.53. In terms of profitability, USNA's ROE is -0.04%, compared to PHH's ROE of +0.38%. Regarding short-term risk, USNA is less volatile compared to PHH. This indicates lower risk in terms of short-term price fluctuations for USNA.Check PHH's competition here
Bruush Oral Care Inc. (NASDAQ: BRSH)
USNA vs BRSH Comparison August 2026
USANA Health Sciences, Inc. (NYSE: USNA) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USNA stands at 243M. In comparison, BRSH has a market cap of 8.7M. Regarding current trading prices, USNA is priced at $13.27 on the NYSE, while BRSH trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USNA currently has a P/E ratio of 13.29, whereas BRSH's P/E ratio is -0.01. In terms of profitability, USNA's ROE is -0.04%, compared to BRSH's ROE of +1.19%. Regarding short-term risk, USNA is less volatile compared to BRSH. This indicates lower risk in terms of short-term price fluctuations for USNA.Check BRSH's competition here
Tantech Holdings Ltd (NASDAQ: TANH)
USNA vs TANH Comparison August 2026
USANA Health Sciences, Inc. (NYSE: USNA) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USNA stands at 243M. In comparison, TANH has a market cap of 5.3M. Regarding current trading prices, USNA is priced at $13.27 on the NYSE, while TANH trades at $0.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USNA currently has a P/E ratio of 13.29, whereas TANH's P/E ratio is 0.04. In terms of profitability, USNA's ROE is -0.04%, compared to TANH's ROE of -0.25%. Regarding short-term risk, USNA is less volatile compared to TANH. This indicates lower risk in terms of short-term price fluctuations for USNA.Check TANH's competition here
Park Ha Biological Technology Co., Ltd. Ordinary Shares (NASDAQ: BYAH)
USNA vs BYAH Comparison August 2026
USANA Health Sciences, Inc. (NYSE: USNA) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USNA stands at 243M. In comparison, BYAH has a market cap of 2.2M. Regarding current trading prices, USNA is priced at $13.27 on the NYSE, while BYAH trades at $2.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USNA currently has a P/E ratio of 13.29, whereas BYAH's P/E ratio is N/A. In terms of profitability, USNA's ROE is -0.04%, compared to BYAH's ROE of -1.74%. Regarding short-term risk, USNA is less volatile compared to BYAH. This indicates lower risk in terms of short-term price fluctuations for USNA.Check BYAH's competition here
Bruush Oral Care Inc. (NASDAQ: BRSHW)
USNA vs BRSHW Comparison August 2026
USANA Health Sciences, Inc. (NYSE: USNA) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USNA stands at 243M. In comparison, BRSHW has a market cap of 6.1K. Regarding current trading prices, USNA is priced at $13.27 on the NYSE, while BRSHW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USNA currently has a P/E ratio of 13.29, whereas BRSHW's P/E ratio is N/A. In terms of profitability, USNA's ROE is -0.04%, compared to BRSHW's ROE of +1.19%. Regarding short-term risk, USNA is less volatile compared to BRSHW. This indicates lower risk in terms of short-term price fluctuations for USNA.Check BRSHW's competition here
Elizabeth Arden, Inc. (NASDAQ: RDEN)
USNA vs RDEN Comparison August 2026
USANA Health Sciences, Inc. (NYSE: USNA) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USNA stands at 243M. In comparison, RDEN has a market cap of 0. Regarding current trading prices, USNA is priced at $13.27 on the NYSE, while RDEN trades at $13.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USNA currently has a P/E ratio of 13.29, whereas RDEN's P/E ratio is -5.68. In terms of profitability, USNA's ROE is -0.04%, compared to RDEN's ROE of -0.77%. Regarding short-term risk, USNA is more volatile compared to RDEN. This indicates higher risk in terms of short-term price fluctuations for USNA.Check RDEN's competition here
Revlon, Inc. (NYSE: REV)
USNA vs REV Comparison August 2026
USANA Health Sciences, Inc. (NYSE: USNA) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USNA stands at 243M. In comparison, REV has a market cap of 0. Regarding current trading prices, USNA is priced at $13.27 on the NYSE, while REV trades at $3.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USNA currently has a P/E ratio of 13.29, whereas REV's P/E ratio is -1.19. In terms of profitability, USNA's ROE is -0.04%, compared to REV's ROE of +0.89%. Regarding short-term risk, USNA is less volatile compared to REV. This indicates lower risk in terms of short-term price fluctuations for USNA.Check REV's competition here
Grove Collaborative Holdings, Inc. (NYSE: GROV-WT)
USNA vs GROV-WT Comparison August 2026
USANA Health Sciences, Inc. (NYSE: USNA) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USNA stands at 243M. In comparison, GROV-WT has a market cap of 0. Regarding current trading prices, USNA is priced at $13.27 on the NYSE, while GROV-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USNA currently has a P/E ratio of 13.29, whereas GROV-WT's P/E ratio is N/A. In terms of profitability, USNA's ROE is -0.04%, compared to GROV-WT's ROE of -0.83%. Regarding short-term risk, USNA is more volatile compared to GROV-WT. This indicates higher risk in terms of short-term price fluctuations for USNA.Check GROV-WT's competition here
Summer Infant, Inc. (NASDAQ: SUMR)
USNA vs SUMR Comparison August 2026
USANA Health Sciences, Inc. (NYSE: USNA) plays a significant role within the Consumer Defensive sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USNA stands at 243M. In comparison, SUMR has a market cap of 0. Regarding current trading prices, USNA is priced at $13.27 on the NYSE, while SUMR trades at $11.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USNA currently has a P/E ratio of 13.29, whereas SUMR's P/E ratio is -3.66. In terms of profitability, USNA's ROE is -0.04%, compared to SUMR's ROE of -0.75%. Regarding short-term risk, USNA is more volatile compared to SUMR. This indicates higher risk in terms of short-term price fluctuations for USNA.Check SUMR's competition here